Tilray | TRLY - Trade Creditors


Tilray reported $114.5M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Acasti Pharma USD 459K 881K Sep/2025
Akebia Therapeutics USD 8.39M 12.8M Mar/2026
Alaunos Therapeutics USD 400K 213K Mar/2026
Aurora Cannabis CAD 68.03M 18.68M Dec/2025
Avita Medical AUD 8.96M 1.69M Dec/2025
Canopy Growth CAD 19.96M 1.83M Dec/2025
Cronos Group USD 10.28M 1.36M Mar/2026
Dianthus Therapeutics USD 5.27M 4.45M Mar/2026
Divis Laboratories Ltd INR 12.11B 1.71B Mar/2026
Ionis Pharmaceuticals USD 26.03M 2.05M Mar/2026
IQVIA Holdings USD 3.64B 112M Mar/2026
Knight Therapeutics CAD 125.76M 7.63M Dec/2025
Moderna USD 161M 156M Mar/2026
Organigram Holdings CAD 71.08M 18.17M Dec/2025
Organon & Co USD 983M 31M Mar/2026
Revvity USD 169.68M 15.78M Mar/2026
Tectonic Therapeutic USD 2.55M 1.46M Mar/2026
Tilray USD 114.5M 3.69M Sep/2025
Viatris USD 1.2B 93.9M Mar/2026
Xeris Pharmaceuticals USD 11.47M 8.39M Mar/2026
Zealand Pharma A/S 346.6M 102.71M Dec/2025